Front Immunol. 2026 May 29;17:1724930.doi: 10.3389/fimmu.2026.1724930.(IF:7).
2026-05-29Front Immunol. 2026 May 29;17:1724930.doi: 10.3389/fimmu.2026.1724930. Machine learning-based identification of an oxidative phosphorylation signature for prognosis, immune infiltration, and drug sensitivity in ovarian cancer. (IF:7).